Hypoxia and the Immune Landscape in Infection and Cancer

A special issue of Cells (ISSN 2073-4409). This special issue belongs to the section "Cellular Immunology".

Deadline for manuscript submissions: 10 July 2026 | Viewed by 3

Special Issue Editor


E-Mail Website
Guest Editor
Research Centre for Health & Life Sciences, Coventry University, Coventry, UK
Interests: macrophages; hypoxia; cancer; infection; innate immunity; biomaterials; gene expression

Special Issue Information

Dear Colleagues,

Hypoxia profoundly influences the immune landscape in both infection and cancer. In infection, hypoxia develops in abscesses, granulomas and inflamed tissues as pathogens and leukocytes consume oxygen, affecting phagocyte recruitment, antimicrobial effector functions and myeloid cell survival and activation.

In solid tumors, rapid cell proliferation often outpaces blood vessel formation, resulting in the development of hypoxic regions. Hypoxia triggers metabolic dysregulation and adaptive responses, including the suppression of effector cell responses, the recruitment of immunosuppressive cells, and the upregulation of immune-evasion molecules, which are detrimental to anti-tumor immunity.

Many, but not all, of the observed changes in infection and cancer are mediated by hypoxia-inducible transcription factors (HIFs), primarily HIF-1 and HIF-2.

This Special Issue seeks original papers and reviews on the mechanisms by which hypoxia alters immune responses in both infection and cancer, and the impact of these changes on health and disease outcomes.

Dr. Bernard Burke
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cells is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • hypoxia
  • tumor
  • infection
  • HIFs
  • immune checkpoint proteins
  • immune evasion
  • metabolic dysregulation
  • leukocyte recruitment
  • effector cell function
  • acidosis

Benefits of Publishing in a Special Issue

  • Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
  • Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
  • Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
  • External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
  • Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.

Further information on MDPI's Special Issue policies can be found here.

Published Papers

This special issue is now open for submission.
Back to TopTop